Identification of T-cell receptors targeting KRAS-mutated human tumors
QJ Wang, Z Yu, K Griffith, K Hanada, NP Restifo… - Cancer immunology …, 2016 - AACR
KRAS is one of the most frequently mutated proto-oncogenes in human cancers. The
dominant oncogenic mutations of KRAS are single amino acid substitutions at codon 12, in …
dominant oncogenic mutations of KRAS are single amino acid substitutions at codon 12, in …
Validation of biomarkers to predict response to immunotherapy in cancer: volume I—pre-analytical and analytical validation
GV Masucci, A Cesano, R Hawtin, S Janetzki… - … for immunotherapy of …, 2016 - Springer
Immunotherapies have emerged as one of the most promising approaches to treat patients
with cancer. Recently, there have been many clinical successes using checkpoint receptor …
with cancer. Recently, there have been many clinical successes using checkpoint receptor …
Retrieval and investigation of data on SARS-CoV-2 and COVID-19 using bioinformatics approach
Sudden emergence and a rapid outbreak of SARS-CoV-2 accompanied by a devastating
impact on the economy and public health has driven extensive scientific mobilization to …
impact on the economy and public health has driven extensive scientific mobilization to …
Immunoinformatics and epitope prediction in the age of genomic medicine
L Backert, O Kohlbacher - Genome medicine, 2015 - Springer
Immunoinformatics involves the application of computational methods to immunological
problems. Prediction of B-and T-cell epitopes has long been the focus of immunoinformatics …
problems. Prediction of B-and T-cell epitopes has long been the focus of immunoinformatics …
Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes
W Zhao, X Sher - PLoS computational biology, 2018 - journals.plos.org
A number of machine learning-based predictors have been developed for identifying
immunogenic T-cell epitopes based on major histocompatibility complex (MHC) class I and II …
immunogenic T-cell epitopes based on major histocompatibility complex (MHC) class I and II …
TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with predicted neoantigen heterogeneity and postsurgical recurrence
Genomic intratumor heterogeneity (ITH) may be associated with postsurgical relapse of
localized lung adenocarcinomas. Recently, mutations, through generation of neoantigens …
localized lung adenocarcinomas. Recently, mutations, through generation of neoantigens …
Designing neoantigen cancer vaccines, trials, and outcomes
Neoantigen vaccines are based on epitopes of antigenic parts of mutant proteins expressed
in cancer cells. These highly immunogenic antigens may trigger the immune system to …
in cancer cells. These highly immunogenic antigens may trigger the immune system to …
Pan-specific prediction of peptide–MHC class I complex stability, a correlate of T cell immunogenicity
M Rasmussen, E Fenoy, M Harndahl… - The Journal of …, 2016 - journals.aai.org
Binding of peptides to MHC class I (MHC-I) molecules is the most selective event in the
processing and presentation of Ags to CTL, and insights into the mechanisms that govern …
processing and presentation of Ags to CTL, and insights into the mechanisms that govern …
HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity
Prediction of HLA binding affinity is widely used to identify candidate T cell epitopes, and an
affinity of 500 nM is routinely used as a threshold for peptide selection. However, the fraction …
affinity of 500 nM is routinely used as a threshold for peptide selection. However, the fraction …
Durable complete response to neoantigen-loaded dendritic-cell vaccine following anti-PD-1 therapy in metastatic gastric cancer
Z Guo, Y Yuan, C Chen, J Lin, Q Ma, G Liu… - NPJ Precision …, 2022 - nature.com
Neoantigens are ideal targets for dendritic cell (DC) vaccines. So far, only a few neoantigen-
based DC vaccines have been investigated in clinical trials. Here, we reported a case of a …
based DC vaccines have been investigated in clinical trials. Here, we reported a case of a …